Print Page | Sign In | Join Today
News & Press: New Members


Tuesday, July 23, 2019  
Share |
KeViRx, Inc., spun out of the University of Pittsburgh and University of Virginia, is an early stage drug discovery company whose mission is to advance new anticancer therapeutics to clinical testing. KeViRx focuses on novel molecular targets for cancer with a goal to discover safer and more effective drugs that enable people to live longer and to live well. KeViRx is advancing KVR-053 targeted drug discovery programs in ovarian, colorectal and breast cancers.

Our Premium Partners

Sign up for our newsletter
800 E. Leigh St.  |  Richmond, Va 23219-1534  |  PH: 804.643.6360  |  Email Us
Stay Connected